Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts


Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Argatroban - Generic Drug Details

« Back to Dashboard
Argatroban is the generic ingredient in four branded drugs marketed by Fresenius Kabi Usa, Mylan Institutional, Eagle Pharms, Sandoz, Hikma Pharm Co Ltd, Par Sterile Products, Teva Pharms Usa, and Pfizer, and is included in nine NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has seven patent family members in five countries.

There are ten drug master file entries for argatroban. Seven suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: argatroban

Tradenames:4
Patents:2
Applicants:8
NDAs:9
Drug Master File Entries: see list10
Suppliers / Packaging: see list7
Formulation / Manufacturing:see details

Tentative approvals for ARGATROBAN

Applicant Application No. Form Dosage
<disabled><disabled>INJECTABLE; INJECTION250MG/250ML
<disabled><disabled>INJECTABLE; INJECTION100MG

Clinical Trials for: argatroban

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
ARGATROBAN
argatroban
INJECTABLE;INJECTION091665-001Jun 30, 2014RXNo<disabled><disabled>
Sandoz
ARGATROBAN IN DEXTROSE
argatroban
SOLUTION;IV (INFUSION)201743-001May 9, 2011DISCNNo<disabled><disabled>
Mylan Institutional
ARGATROBAN
argatroban
INJECTABLE;INJECTION202626-001Jun 30, 2014RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: argatroban

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
ARGATROBAN
argatroban
INJECTABLE;INJECTION020883-001Jun 30, 20005,214,052<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: argatroban

Country Document Number Estimated Expiration
China101516370<disabled in preview>
Japan2010504971<disabled in preview>
European Patent Office2083823<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc